Fact CheckerSign in

NCT05659888Completed

Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPE

PENELOPE-CTRL: Real Life Lipid Management Compared to Protocolized Implementation of the Current Dutch- and ESC-guidelines in Very High-risk CV-patients

Source: ClinicalTrials.gov · Last updated 26 Jul 2024

Brief summary (registry, in English)

Guideline recommended evidence-based clinical care correlates with improved patient outcomes. In real life care, however, adherence to guideline recommendations remains suboptimal. In real life, patients may receive suboptimal treatment and as a result treatment targets are not always met. To support and improve secondary prevention for cardiovascular disease, PENELOPE and PENELOPE-CTRL are designed to support guideline implementation on lipid management and provide valuable feedback to care-givers on real world data.

Status (registry)
Completed
Study type
Observational
Enrollment
827 (actual)
First submitted
12 Dec 2022
Start date
25 Jul 2022
Primary completion date
31 Jan 2023
Lead sponsor
Clinical Operations WCN B.V.
NCT number
NCT05659888

What you commit to

  • Study type: Observational
  • Participants enrolled: 827
  • From 25 Jul 2022 to the primary completion date, 31 Jan 2023
  • 13 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in lipid modifying drug trials up to two years after index cardiovascular event

Other

  • Pregnant and lactating women

Who the study is looking for

  • Age \>18 and ≤70 years
  • Alive at hospital discharge after admission for (N)STEMI between 1-1-2019 and 31-08-2020
  • Planned for follow-up at a participating PENELOPE CTRL site
  • History of T2DM and/or history of ASCVD defined as either one of:
    • cerebrovascular disease/ event: transient ischemic attack, cerebral infarction, amaurosis fugax, retinal infarction
    • Coronary artery disease/ event: unstable angina pectoris, MI, ACS, coronary revascularization (coronary angioplasty or surgical procedure for coronary bypass)
    • Peripheral artery disease (symptomatic and documented obstruction of a distal extremity artery or surgical intervention (percutaneous transluminal angioplasty, bypass or amputation)

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NoordWest Hospital (NWZ)
Coordinator of this site? Confirm its status
AlkmaarNetherlandsUnknown status
Reinier de Graaf Hospital
Coordinator of this site? Confirm its status
DelftNetherlandsUnknown status
Deventer Hospital
Coordinator of this site? Confirm its status
DeventerNetherlandsUnknown status
Treant Hospital
Coordinator of this site? Confirm its status
EmmenNetherlandsUnknown status
Saxenburg Medisch Centrum
Coordinator of this site? Confirm its status
HardenbergNetherlandsUnknown status
Elkerliek Hospital
Coordinator of this site? Confirm its status
HelmondNetherlandsUnknown status
Alrijne Hospital
Coordinator of this site? Confirm its status
LeidenNetherlandsUnknown status
Isala Hospital
Coordinator of this site? Confirm its status
MeppelNetherlandsUnknown status
Canisius Wilhemina Hospital (CWZ)
Coordinator of this site? Confirm its status
NijmegenNetherlandsUnknown status
Haaglanden Hospital
Coordinator of this site? Confirm its status
The HagueNetherlandsUnknown status
Haga Hospital
Coordinator of this site? Confirm its status
The HagueNetherlandsUnknown status
Diakonessenhuis Utrecht
Coordinator of this site? Confirm its status
UtrechtNetherlandsUnknown status
Maxima Medisch Centrum
Coordinator of this site? Confirm its status
VeldhovenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.